FDA approves much-debated Alzheimer's drug panned by experts
by Matthew PerroneIn this 2019 photo provided by Biogen, a researcher works on the development of the medication aducanumab in Cambridge, Mass. On Monday, June 7, 2021, the Food and Drug Administratio
Updated on: March 30,2024
12
FDA approves much-debated Alzheimer's drug panned by experts
by Matthew PerroneIn this 2019 photo provided by Biogen, a researcher works on the development of the medication aducanumab in Cambridge, Mass. On Monday, June 7, 2021, the Food and Drug Administratio
Updated on:March 30,2024
12
